[PDF][PDF] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
…, S Adele, N Meardon, S Faustini, S Al-Taei… - Cell, 2021 - cell.com
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production
Extracellular adenosine is elevated in cancer tissue, and it negatively regulates local
immune responses. Adenosine production from extracellular ATP has attracted attention as a …
immune responses. Adenosine production from extracellular ATP has attracted attention as a …
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
…, M Perez-Toledo, S Jossi, E Aldera, JD Allen, S Al-Taei… - Thorax, 2020 - thorax.bmj.com
Objective To determine the rates of asymptomatic viral carriage and seroprevalence of
SARS-CoV-2 antibodies in healthcare workers. Design A cross-sectional study of asymptomatic …
SARS-CoV-2 antibodies in healthcare workers. Design A cross-sectional study of asymptomatic …
Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia …
MM Fretz, NA Penning, S Al-Taei, S Futaki… - Biochemical …, 2007 - portlandpress.com
Delineating the mechanisms by which cell-penetrating peptides, such as HIV-Tat peptide,
oligoarginines and penetratin, gain access to cells has recently received intense scrutiny. …
oligoarginines and penetratin, gain access to cells has recently received intense scrutiny. …
Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
Exosomes are a distinct population of extracellular vesicles of endocytic origin with a
protein repertoire similar to the parent cell. Although tumour-derived exosomes harbour …
protein repertoire similar to the parent cell. Although tumour-derived exosomes harbour …
Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors
S Al-Taei, NA Penning, JC Simpson… - Bioconjugate …, 2006 - ACS Publications
Transduction domains such as those derived from the HIV-TAT protein are candidate vectors
for intracellular delivery of therapeutic macromolecules such as DNA and proteins. The …
for intracellular delivery of therapeutic macromolecules such as DNA and proteins. The …
[PDF][PDF] COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
…, U Amin, S Nicol, C Stephens, S Faustini, S Al-Taei… - Cancer Cell, 2022 - cell.com
B cell chronic lymphocytic leukemia (CLL) is the most common subtype of adult leukemia
and is associated with profound secondary immunodeficiency. SARS-CoV-2 infection has …
and is associated with profound secondary immunodeficiency. SARS-CoV-2 infection has …
[PDF][PDF] Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
…, LS Reyes, N Meardon, S Faustini, S Al-Taei… - Med, 2023 - cell.com
Background Both infection and vaccination, alone or in combination, generate antibody and
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …
Effects of Na+/H+ exchanger inhibitors on subcellular localisation of endocytic organelles and intracellular dynamics of protein transduction domains HIV–TAT peptide …
…, J Jin, R Conibere, NA Penning, S Al-Taei… - Journal of Controlled …, 2006 - Elsevier
Protein transduction domains such as those derived from the HIV protein TAT have great
potential as vectors for delivery of therapeutic entities such as genes and proteins into cells. …
potential as vectors for delivery of therapeutic entities such as genes and proteins into cells. …
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody …
…, S Jossi, JD Allen, S Al-Taei… - BMJ open …, 2021 - bmjopenrespres.bmj.com
Objective To determine clinical and ethnodemographic correlates of serological responses
against the SARS-CoV-2 spike glycoprotein following mild-to-moderate COVID-19. Design A …
against the SARS-CoV-2 spike glycoprotein following mild-to-moderate COVID-19. Design A …